The cell cycle and G1-S phase transition are of a therapeutic interest in pancreatic cancer where the cycle regulator p15, encoded by CDKN2B gene is frequently deleted or mutated [66]. This evidence concerns the gene CDKN2B and familial pancreatic carcinoma.